Results 131 to 140 of about 15,628 (311)

Gastrointestinal Safety Assessment of GLP-1 Receptor Agonists in the US: A Real-World Adverse Events Analysis from the FAERS Database

Diagnostics
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are commonly used to treat obesity and diabetes but are linked to a variety of gastrointestinal (GI) adverse events (AEs).
Samuel Prince Osei, Edwin Akomaning, Teodora Francesca Florut, M. Sodhi, Brian E. Lacy, W. Aldhaleei, A. Bhagavathula   +6 more
semanticscholar   +1 more source

Toxicity spectrum of pegvaliase: A pharmacovigilance analysis using the FAERS database

Orphanet Journal of Rare Diseases
Objective This research aimed to assess the safety of pegvaliase through analyzed the data from the FAERS database, thus providing a theoretical foundation for the rational and safe application of pegvaliase in clinical settings.
Luyao Xu, Kaili Mao, Songyang Zhong, Huayu Sun, Hongliang Zheng, Zhenling Fu   +5 more
doaj   +1 more source

Adverse Events of Oral GLP-1 Receptor Agonist (Semaglutide Tablets): A Real-World Study Based on FAERS from 2019 to 2023

Diabetes Therapy
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have attracted much attention because of their significant hypoglycemic and weight-loss effects. Previous preparations can only be subcutaneously injected.
Si Xiong, Ruoyu Gou, Xudong Liang, Hao Wu, Shuitao Qin, Bing Li, Changjun Luo, Junan Chen   +7 more
semanticscholar   +1 more source

PHARMACOVİGİLANCE OF DRUG-INDUCED LEUKEMİA: A DESCRİPTİVE STUDY OF FDA ADVERSE EVENT REPORTİNG SYSTEM FROM 1969-2024

Hematology, Transfusion and Cell Therapy
Background: Drug-induced leukemia is a recognized adverse drug reaction associated with specific classes of medications. This study aims to quantify the frequency of leukemia-related adverse drug reactions and identify the medications most implicated as ...
Ahmet Sarici, Lokman Hekim Tanriverdi
doaj   +1 more source

Safety assessment of sulfasalazine: a pharmacovigilance study based on FAERS database

Frontiers in Pharmacology
Background Sulfasalazine is a widely used anti-inflammatory medication for treating autoimmune disorders such as ulcerative colitis (UC), Crohn’s disease, and rheumatoid arthritis. However, its safety profile has not been systematically evaluated in real-
Wangyu Ye, Yuan Ding, Meng Li, Zhihua Tian, Shaoli Wang, Zhen Liu   +5 more
semanticscholar   +1 more source

What Is FAER? [PDF]

Anesthesiology, 2011
Denham S, Ward, Carl C, Hug, James R, Zaidan, Alan D, Sessler   +3 more
openaire   +2 more sources

Opportunities and Challenges of Using Big Data to Detect Drug-Drug Interaction Risk [PDF]

, 2019
Chasioti D., Institute of Medicine Committee on Data Standards for Patient Safety   +1 more
core   +1 more source

Vonoprazan-associated infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System

Therapeutic Advances in Drug Safety
Background: Prolonged or excessive use of acid suppressants may increase the risk of Clostridioides difficile infection (CDI) by altering the intestinal microecosystem.
Mengling Ouyang, Shupeng Zou, Qian Cheng, Xuan Shi, Yazheng Zhao, Minghui Sun   +5 more
doaj   +1 more source

Iowa Board of Pharmacy News, September 2015 [PDF]

, 2015
The Iowa Board of Pharmacy News is published by the Iowa Board of Pharmacy and the National Association of Boards of Pharmacy Foundation, Inc, to promote compliance of pharmacy and drug ...

core  

Ocular adverse events associated with antibody-drug conjugates in oncology: a pharmacovigilance study based on FDA adverse event reporting system (FAERS)

Frontiers in Pharmacology
Background Antibody-drug conjugates (ADCs) have emerged as the focus and hotspots in the cancer field, yet the accompanying ocular toxicity has often been underestimated.
KaiLi Mao, Ping Chen, Huayu Sun, Songyang Zhong, Hongliang Zheng, Luyao Xu   +5 more
semanticscholar   +1 more source